FDA Delays Decision on HIV Pill

June 10, 2012

June 11, 2012 | FDA has announced a delay in its decision on Gilead Sciences' HIV-prevention pill, choosing to take another three months to review the application and supporting materials. An external panel voted in May to approve the drug. While FDA often takes the advice of the panel, their decision is nonbinding. San Francisco Chronicle